Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ingevity (NGVT) Cost of Revenue (2016 - 2025)

Ingevity (NGVT) has disclosed Cost of Revenue for 11 consecutive years, with $109.1 million as the latest value for Q4 2025.

  • On a quarterly basis, Cost of Revenue fell 33.23% to $109.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $706.1 million, a 3.97% decrease, with the full-year FY2025 number at $706.1 million, down 3.97% from a year prior.
  • Cost of Revenue was $109.1 million for Q4 2025 at Ingevity, down from $199.2 million in the prior quarter.
  • In the past five years, Cost of Revenue ranged from a high of $328.8 million in Q2 2023 to a low of -$137.5 million in Q4 2023.
  • A 5-year average of $209.4 million and a median of $233.0 million in 2021 define the central range for Cost of Revenue.
  • Peak YoY movement for Cost of Revenue: tumbled 149.42% in 2023, then surged 218.84% in 2024.
  • Ingevity's Cost of Revenue stood at $231.0 million in 2021, then rose by 20.43% to $278.2 million in 2022, then crashed by 149.42% to -$137.5 million in 2023, then soared by 218.84% to $163.4 million in 2024, then crashed by 33.23% to $109.1 million in 2025.
  • Per Business Quant, the three most recent readings for NGVT's Cost of Revenue are $109.1 million (Q4 2025), $199.2 million (Q3 2025), and $227.2 million (Q2 2025).